These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38735968)

  • 21. Angiographic and clinical outcomes after implantation of drug eluting stents in bifurcation lesions with crush or kissing stent technique.
    Cheema AN; Jolly SS; Burstein JM; Sharieff W; Mohammad A; Yeoh E; Mancini GB; Cantor WJ; Kutryk MJ; Strauss BH; Chisholm RJ
    J Interv Cardiol; 2013 Apr; 26(2):145-52. PubMed ID: 23406435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.
    Burzotta F; Trani C; Todaro D; Mariani L; Talarico GP; Tommasino A; Giammarinaro M; Niccoli G; Porto I; Leone AM; Mongiardo R; Mazzari MA; Schiavoni G; Crea F
    JACC Cardiovasc Interv; 2011 Mar; 4(3):327-35. PubMed ID: 21435612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results From the International Drug Coated Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated Without Stents?
    Bruch L; Zadura M; Waliszewski M; Platonic Z; Eränen J; Scheller B; Götting B; Herberger D; Palmieri C; Sinicròpi G; Motz W
    J Interv Cardiol; 2016 Aug; 29(4):348-56. PubMed ID: 27242273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel hybrid strategy of drug coated balloon and stent for coronary bifurcation lesions.
    Yang H; Song Y; Cao J; Chen J; Zhang F; Huang Z; Qian J; Ge J
    Scand Cardiovasc J; 2023 Dec; 57(1):2161620. PubMed ID: 36573618
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-coated balloon in the treatment of coronary artery de-novo large lesions angiography.
    Cai X; Hong X; Wang Y; Li Y; Xu G
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):196-201. PubMed ID: 38678606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial.
    Berland J; Lefèvre T; Brenot P; Fajadet J; Motreff P; Guerin P; Dupouy P; Schandrin C;
    EuroIntervention; 2015 Dec; 11(8):868-76. PubMed ID: 26696455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
    Généreux P; Kumsars I; Lesiak M; Kini A; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB
    J Am Coll Cardiol; 2015 Feb; 65(6):533-43. PubMed ID: 25677311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute.
    Yu X; Ji F; Xu F; Zhang W; Wang X; Lu D; Yang C; Wang F
    Clin Res Cardiol; 2019 Mar; 108(3):234-243. PubMed ID: 30074078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: an angiographic follow up study.
    Kaul U; Unverdorben M; Degenhardt R; Seth A; Bahl VK; Hiremath SM; Chandra P; Mullesari AS; Sandhu PS; Rao S; George O; Ackermann H; Boxberger M
    Indian Heart J; 2013; 65(5):510-7. PubMed ID: 24206873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design for comparison of non-compliant balloon with drug-coating balloon angioplasty for side branch after provisional stenting for patients with true coronary bifurcation lesions: a prospective, multicentre and randomised DCB-BIF trial.
    Gao XF; Ge Z; Kan J; Kong XQ; Wang Y; Qiu CG; Tresukosol D; He YQ; Wu Q; Li JF; Yuan HT; Shen C; Chen X; Munawar M; Hanif B; Santoso T; Shin ES; Sheiban I; Ye F; Zhang JJ; Chen SL;
    BMJ Open; 2022 Mar; 12(3):e052788. PubMed ID: 35277400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.
    Sim HW; Ananthakrishna R; Chan SP; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Tan HC; Loh JP
    J Invasive Cardiol; 2018 Jul; 30(7):256-261. PubMed ID: 29656281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of drug-coated balloon combined with cutting balloon for side branch of true coronary bifurcation lesions: Study protocol for a multicenter, prospective, randomized controlled trial.
    Wu H; Deng J; Liang L; Lei X; Yao X; Han W; Chen H; Shou X
    Front Cardiovasc Med; 2022; 9():1035728. PubMed ID: 36407430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
    Merinopoulos I; Gunawardena T; Corballis N; Tsampasian V; Vassiliou V; Eccleshall S; Ryding A; Xydopoulos G
    Catheter Cardiovasc Interv; 2023 Nov; 102(6):987-996. PubMed ID: 37925618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.
    Kook H; Joo HJ; Park JH; Hong SJ; Yu CW; Lim DS
    BMC Cardiovasc Disord; 2020 Feb; 20(1):83. PubMed ID: 32070287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mid-term results of stent-less coronary intervention using rotational atherectomy and drug-coated balloon for de-novo lesions in hemodialysis patients.
    Shiraishi J; Asano Y; Kakei Y; Ito F; Yoshimura J; Kataoka E; Ozawa T; Ito D; Kojima A; Kimura M; Kishita E; Nakagawa Y; Hyogo M; Sawada T
    Minerva Cardiol Angiol; 2023 Jun; 71(3):294-302. PubMed ID: 35837831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery.
    Gitto M; Sticchi A; Chiarito M; Novelli L; Leone PP; Mincione G; Oliva A; Condello F; Rossi ML; Regazzoli D; Gasparini G; Cozzi O; Stefanini GG; Condorelli G; Reimers B; Mangieri A; Colombo A
    Circ Cardiovasc Interv; 2023 Dec; 16(12):e013232. PubMed ID: 37874646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial.
    Cortese B; Di Palma G; Guimaraes MG; Piraino D; Orrego PS; Buccheri D; Rivero F; Perotto A; Zambelli G; Alfonso F
    JACC Cardiovasc Interv; 2020 Dec; 13(24):2840-2849. PubMed ID: 33248978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.